← Back to news
May 1, 2026

Fifth Circuit Court Blocks Telehealth and Mail Distribution of Mifepristone, Restoring In-Person Prescription Requirement

  • The Fifth U.S. Circuit Court of Appeals has blocked the telehealth and mail distribution of mifepristone, requiring in-person visits for prescriptions.
  • The ruling reinstates safety protocols that were lifted during the COVID-19 pandemic, which critics argue will restrict access even in states where abortion is legal.
  • The decision is expected to be appealed to the Supreme Court, potentially impacting federal authority over abortion drug regulation.